North America Cardiovascular Needle Market Analysis, Size, and Share by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

North America Cardiovascular Needle Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Round-Bodied Needles, and Cutting Needles); Application (Open Heart Surgery, and Cardiac Valve Procedures); Usage (Single Use, and Multiple Uses); End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Cardiovascular Centers)

  • Report Date : Nov 2021
  • Report Code : TIPRE00025905
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 104
Page Updated: Nov 2021

The cardiovascular needle market in North America is expected to grow from US$ 30.55 Million in 2021 to US$ 50.85 Million by 2028; it is estimated to grow at a CAGR of 7.5% from 2021 to 2028.

Cardiovascular diseases (CVDs) are the disorders of heart and blood vessels, and the category includes cerebrovascular disease, coronary heart disease, rheumatic heart disease, and other conditions. Tobacco consumption, unhealthy diet, and physical inactivity, which increase the risk of heart attacks and strokes, are a few of the major lifestyle factors that lead to the CVDs. Other risk factors causing these diseases include hypertension, diabetes, and increased cholesterol levels. CVDs are among the top 10 causes of death. According to the World Health Organization (WHO), cardiovascular diseases are number one cause of the death. Cardiovascular diseases (CVDs) are likely to remain the largest cause of morbidity and mortality. Fat depositions around blood vessels that prevents blood from flowing to the heart or brain is a main cause of heart attack and stroke. Bleeding vessels or blood clots in brain are a few other causes of stroke. Furthermore, as per the American Heart Association (AHA) 2019 statistics, 121.5 million adults in the US, i.e., ~50% of the US adult population, suffer from CVDs every year. Thus, the significantly rising incidence of CVDs is contributing to the high demand for diagnostic and treatment cardiovascular devices, which is driving the cardiovascular needle market growth.

Cardiac surgical patients not only require vital ICU resources but are also potentially in the highest risk category of complications of COVID-19. Hence, most of the hospitals and surgical enters has considered to cancel or postponed elective surgeries including cardiovascular surgeries. Hence impact of COVID 19 is expected to be somewhat negative on cardiovascular needle market, but it is also anticipated for short term. According to the Society of Thoracic Surgeons Adult Cardiac Surgery Database and Johns Hopkins COVID-19 database, there was a 52.7% reduction in adult cardiac surgery volume and a 65.5% reduction in elective cases in United States. After the first COVID-19 surge, nationwide cardiac surgical case volumes have declined, which indicates a COVID-19-associated impact on cardiac surgery patients. However, in long run, as the vaccination schedule will establishes and transmission rate decreases, healthcare systems will return to normal and will have increased demand for cardiovascular needle, which will support the market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the cardiovascular needle market. The North America cardiovascular needle market is expected to grow at a good CAGR during the forecast period.

North America cardiovascular needle market

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

North America Cardiovascular Needle Market Segmentation    

By Application

  • Open Heart Surgery
  • Cardiac Valve Procedures

By Usage

  • Single Use
  • Multiple Uses

By End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centres
  • Cardiovascular Centres

By Country

  • North America
    • US
    • Canada
    • Mexico

Companies Mentioned

  • Ethicon (Johnson & Johnson Services, Inc.)    
  • MANI, INC         
  • Barber of Sheffield       
  • FSSB surgical needles GmbH    
  • Medtronic         
  • Teleflex Incorporated    
  • Meril Life Sciences Pvt. Ltd.      
  • CP Medical        
  • SMB Corporation of India

North America Cardiovascular Needle Report Scope

Report Attribute Details
Market size in 2021 US$ 30.55 Million
Market Size by 2028 US$ 50.85 Million
Global CAGR (2021 - 2028) 7.5%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type
  • Round-Bodied Needles
  • Cutting Needles
By Application
  • Open Heart Surgery
  • Cardiac Valve Procedures
By Usage
  • Single Use
  • Multiple Uses
By End User
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Cardiovascular Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Ethicon (Johnson & Johnson Services, Inc.)
  • MANI, INC
  • Barber of Sheffield
  • FSSB surgical needles GmbH
  • Medtronic
  • Teleflex Incorporated
  • Meril Life Sciences Pvt. Ltd.
  • CP Medical
  • SMB Corporation of India
  • Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Our Clients
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo